Wire · opportunities
FDA Approves First Drug to Treat Alexander Disease
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 4 September 2026 · Fusion42 review
The FDA has approved Zanvastro (zilganersen), the first drug to treat Alexander disease by directly targeting the disease's underlying cause, marking a landmark regulatory approval for this rare neurological disorder.
This Wire brief sits within Fusion42's coverage of Biotech, and 3 sources have reported it.
◆ ◆ The Wire takeaway
Biotech founders targeting ultra-rare diseases should move fast to explore RNA-targeting therapies like antisense oligonucleotides as regulatory support for such approaches is rising. New approvals like this create openings to engage specialists in rare neurology with fewer competitors.
◆ Coverage
3 sources · 3 Sep 2026
◆ Related on Wire
◆ Topics